Clave is a venture capital firm situated in Pamplona, Spain, boasting two decades of experience in the investment domain. Throughout their history, they have executed more than 90 investments and have played an active role in shaping the strategies and managing the affairs of the businesses they have supported.
Their portfolio displays a keen focus on projects that foster technological transfer, particularly within small and medium-sized industrial enterprises, and initiatives in the renewable energy sector.
Clave is responsible for managing funds that collectively amass to 90 million euros, showcasing their significant presence in the investment environment.
They are currently in the process of launching a new fund, amounting to another 80 million euros, dedicated to propelling technological transfer projects within the health sector. This new fund is influential, with sectors like medtech, ehealth, nutrition, and biotech being the main focus of the investments.
Clave has a noteworthy partnership with the Centre for the Development of Industrial Technology (CDTI), which operates through its financial instrument INNVIERTE, pledging up to 40 million euros. The remaining capital infusion is anticipated to come from private investors. Clave prides itself on promoting close collaboration with company founders, management teams, investors, and the innovative ecosystem at large.
Their involvement is aimed at bolstering company growth and addressing the emerging challenges of the market. They exhibit a distinct investment thesis that targets innovative health tech transfer, impactful technologies in food tech, business growth in the industrial sector, and investments tailored to new segments in the energy domain.
